KELLIE SOLES: Open Payments
NPI 1104302256 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $303 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| PFIZER INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: XIFAXAN, AIRSUPRA, PREVNAR 20, GARDASIL 9, Veozah, BREZTRI, Kerendia, OTEZLA.
Industry payments across MO — which companies pay providers there.
